Iranian Dove by Equilibrium Genetics: A Comprehensive Strain Guide

History and Breeding of Iranian Dove

Iranian Dove is a mostly indica cultivar bred by Equilibrium Genetics, a California-based seed company known for preserving heirloom traits while optimizing vigor and resin production. The breeder’s catalog leans toward practical, grower-friendly lines that finish in reasonable timeframes, and Iranian Dove slots neatly into that philosophy. The name signals an Iranian Plateau influence, a region historically associated with early-finishing, broadleaf plants selected for hash production and resin density. In the context of contemporary breeding, the 'Dove' moniker hints at a calmer, soothing effect profile rather than an aggressive, racy high.

Publicly available data on this specific strain’s release window is limited, but community mentions began appearing in the late 2010s as Equilibrium Genetics expanded its regional distribution. Growers who encounter the line often note its compact stature and dense bud set consistent with indica-dominant stock. Equilibrium Genetics’ work typically emphasizes stability over flashiness, which makes Iranian Dove an appealing candidate for home gardens and small commercial grows alike. It is positioned as a reliable, resin-forward plant rather than a novelty-driven hype cultivar.

Like many boutique lines with landrace influence, documentation of Iranian Dove’s earliest ancestry is not exhaustive. Industry databases frequently contain placeholders where lineage details are not fully known or publicly released. Resources such as SeedFinder’s genealogy pages even catalog entire branches of 'Unknown Strain' entries to reflect the reality that some breeding histories are either lost or proprietary. Iranian Dove fits into this broader context: recognizable indica performance, with historical roots that are better inferred from traits than conclusively traced on paper.

From a market perspective, indica-dominant cultivars continue to command steady demand for evening use, sleep support, and pain relief niches. Surveys of US retail flower between 2020 and 2023 show minimal decline in indica-leaning sales segments despite an influx of dessert-centric hybrids, suggesting consistent consumer interest. Iranian Dove’s branding and reported effects align with that demand, particularly for those seeking classic, hash-adjacent aromatics over candy-forward terpenes. As a result, it functions as a counterweight to trend cycles while staying firmly relevant to practical consumers.

Genetic Lineage and Ancestry

Equilibrium Genetics lists Iranian Dove as mostly indica, but has not widely published parentage specifics. In practice, 'Iranian' lines are often related to, or selected alongside, Afghan Plateau broadleaf populations that historically deliver dense flowers, fast finishes, and resin-favorable calyx clusters. The 'Dove' name likely denotes a gentle, soothing effect, but that is a breeder’s branding choice rather than a botanical descriptor. Without formal parent disclosure, horticultural inference remains the most reliable method for profiling its ancestry.

Genetic markers can only be verified via lab testing, and as of 2024 there is no publicly available SNP or WGS dataset specific to Iranian Dove. Nonetheless, its growth behavior suggests a high proportion of indica heritage, with short internodes and a tendency to stack flowers along the main stem. Finishing times reported by growers typically land in the 8 to 9-week range indoors, a hallmark of broadleaf-dominant cultivars. Outdoor completion by late September to early October at mid-latitudes further supports this inference.

The broader genealogy of many legacy-influenced lines contains gaps, partly due to informal breeding practices before widespread legal marketplaces. Databases sometimes denote these gaps with 'Unknown Strain' entries; SeedFinder, for instance, maintains extensive genealogies that explicitly track unknown nodes from 'Original Strains' or similar placeholders. Iranian Dove’s partial opaqueness is not unusual and does not diminish its horticultural value. Instead, it places emphasis on observable phenotype and performance rather than documented pedigree.

Practically, growers can treat Iranian Dove as a stabilized indica-leaning line optimized for resin, cold tolerance, and predictable structure. Those traits have strong historical associations with Iranian and Afghan broadleaf populations cultivated for hashish production. If phenotypic selections were made under cooler nights, that would also explain occasional reports of anthocyanin expression. Ultimately, its ancestry tells a familiar story: pragmatic breeding choices honed for resin, reliability, and a comforting end-user experience.

Appearance and Plant Morphology

Iranian Dove presents a compact, squat frame with broad, dark-green leaflets that commonly exhibit five to seven blades. Internodal spacing is short, allowing tight stacking of flowering sites and reducing the need for excessive trellising in small tents. Under high light intensity and proper nutrition, apical dominance remains strong, though lateral branching fills well with minimal training. Overall plant height indoors often ranges from 70 to 120 cm in a 3- to 5-gallon container.

During bloom, buds are dense, rounded to slightly conical, and show a high calyx-to-leaf ratio that simplifies trimming. Pistils start off a vibrant orange to apricot and progressively darken toward amber as maturity approaches. Trichome coverage is thick, with visible capitate-stalked trichomes clustering on bracts and sugar leaves by week six. When nights drop below 18°C (64°F), some phenotypes display purpling in the bracts or leaf veins due to anthocyanin accumulation.

Production-focused cultivators will notice that cola girth increases rapidly between weeks four and seven of flower. That compression of growth into a defined mid-flower window is typical of indica-leaning plants selected for speed and density. The plant’s center of mass stays low compared to lanky sativas, making it easier to manage wind stress outdoors and airflow indoors. With appropriate canopy management, it can be run either as a sea of green (SOG) with many small plants or a SCROG with 1–2 toppings per plant.

Trichome heads tend toward cloudy by day 55–60 under most LED setups at 900–1100 μmol·m⁻²·s⁻¹ PPFD, with amber percentages typically rising past 15% by day 63–66. This creates a manageable harvest window for different effect targets. Growers seeking maximum relaxation often wait until 10–20% amber, while those preferring a slightly brighter effect pull at ~5–10% amber. The visual maturity signs align well with target effects and post-harvest processing goals.

Aroma and Bouquet

Iranian Dove’s bouquet leans earthy, spicy, and woody, with hash-forward overtones that recall classic plateau genetics. The first impression is often musky and herbal, akin to petrichor after rain mixed with dried bay leaf and peppercorn. As flowers are broken up, secondary notes of sandalwood, faint citrus peel, and toasted nuts emerge. The overall effect is sophisticated and restrained rather than candy-sweet.

Myrcene and beta-caryophyllene typically anchor the aromatic profile, delivering musky fruit and peppered spice respectively. Humulene contributes woody, hop-like facets that reinforce the classic hash aroma many associate with Iranian and Afghan lines. Smaller amounts of limonene introduce a subtle brightness that lifts the nose without turning it into a dessert profile. Some phenotypes hint at linalool-driven floral touches, particularly after curing beyond 21 days.

Cure length significantly influences aroma clarity. A slow dry of 10–14 days at ~60°F and 60% RH, followed by a 4–8 week cure at 58–62% RH, reveals a deeper sandalwood-incense register. Total terpene content in well-grown, hand-trimmed flowers often lands around 1.5–3.5% by weight, with standout batches exceeding 4%. High-terpene lots show clear stratification between spice, wood, and faint citrus without muddiness.

When combusted, the aroma leans toward classic hashish with a resinous, incense-like room note. Vaporization at 180–190°C (356–374°F) emphasizes herbal sweetness and reduces the pepper bite. At lower vaporization temperatures (165–175°C, 329–347°F), the bouquet skews softer and more floral. Users consistently describe the nose as comforting, grounded, and nostalgic for old-world indica fans.

Flavor Profile and Mouthfeel

On the palate, Iranian Dove delivers a layered profile of earth, black pepper, and sandalwood with a soft, nutty undertone. The first inhalation tends to be smooth and resinous, with the retrohale revealing myrcene-forward musk and caryophyllene spice. Subsequent draws bring out light citrus zest and a faint dried-fruit character, reminiscent of apricot leather in some phenotypes. The finish is long, clean, and hashy without harshness.

Vaporization provides the clearest flavor separation. At 175–185°C (347–365°F), expect woody-hoppy humulene and peppery caryophyllene to define the mid-palate. Raising temperature to 190–200°C (374–392°F) deepens the sandalwood and brings out a toasted herb quality akin to sage. Combustion narrows the profile but accentuates incense and pepper, a signature many connoisseurs enjoy.

Mouthfeel is medium-bodied with gentle resin grip and minimal throat sting when properly cured. Ash tends to burn light gray to near-white in well-flushed, well-cured flowers, indicating balanced mineral content and complete dry. The absence of cloying sweetness helps with sessionability and avoids palate fatigue. Terp expression remains stable through a typical 0.25–0.35 g session packed in a standard convection vape.

Pairings lean savory. Herbal teas, light-roast coffee, or cardamom-forward chai complement the spice register, while aged cheeses or roasted nuts echo the woody, nutty undertones. Citrus zest or green apple serves as a cleansing palate contrast if you prefer brighter accents. Overall, the flavor is classic and composed rather than novelty-forward.

Cannabinoid Profile and Expected Potency

Lab-verified cannabinoid data specific to Iranian Dove is limited in public databases as of 2024. Given its mostly indica heritage and breeder reputation, the chemotype is likely THC-dominant (Type I). For similar indica-leaning cultivars in US retail data, median THC values commonly range from 18–24%, with premium lots surpassing 25% under optimized conditions. CBD typically remains below 1%, while minor cannabinoids like CBG and CBC may appear in the 0.1–1.0% range combined.

Industry-wide, the average THC of lab-tested flower in legal US markets has hovered around 19–21% in recent years, depending on region and sampling methods. It is reasonable to expect Iranian Dove to align with or slightly exceed that average when grown under high PPFD LEDs and dialed nutrition. Anecdotal reports from growers working with Equilibrium Genetics lines often cite robust potency consistent with modern consumer expectations. However, genotype-by-environment interaction can shift potency by several percentage points.

For concentration makers, Iranian Dove’s resin production and trichome density suggest decent extraction efficiency. Hydrocarbon extractions could yield 15–25% by input weight depending on trim quality and trichome maturity. Rosin yields on quality flower are typically 18–23% under 190–205°F press temperatures with 100–120 μm bags. Live rosin or fresh-frozen approaches may recover more monoterpenes, at the cost of some caryophyllene-heavy warmth in the profile.

If precise potency is critical, third-party testing remains essential. Harvest timing alone can shift total THC by 1–3% and influence THCA to THC ratios after decarboxylation. Likewise, stressors such as heat spikes or nutrient imbalances can depress cannabinoid synthesis. Consistent environmental control is therefore as important as genetic potential in realizing expected potency.

Terpene Profile and Chemical Nuance

While individual batches vary, the dominant terpene suite for Iranian Dove typically centers on beta-myrcene, beta-caryophyllene, and humulene. In well-grown flowers with total terpene content in the 2–3% range, myrcene often appears at 0.5–1.2%, caryophyllene at 0.3–0.9%, and humulene at 0.1–0.4%. Limonene frequently lands between 0.2–0.6%, brightening the nose without changing the core identity. Linalool, ocimene, and terpinolene may appear in trace to modest amounts, adding floral and herbal intricacy.

From a pharmacological perspective, caryophyllene is notable as a CB2 receptor agonist. Preclinical research suggests CB2 engagement may contribute to anti-inflammatory signaling without overt intoxication. Myrcene has been associated with sedative and muscle-relaxant qualities in animal models, which aligns with the perceived calming effect of indica-leaning cultivars. Humulene contributes woody aromatics and has been explored for potential anti-inflammatory properties in vitro.

Total terpene content correlates with perceived aroma intensity and, to a lesser extent, subjective potency. A difference of 0.5 percentage points in total terpenes is readily perceptible to most consumers during side-by-side evaluation. Post-harvest handling exerts a large influence; aggressive drying or high-temperature storage can cause monoterpene loss exceeding 30% in the first month. Properly sealed glass jars, stable temperatures around 60–65°F, and 58–62% RH sustain the bouquet and preserve minor terpenes.

For formulators, Iranian Dove’s terpene composition pairs well with caryophyllene- or linalool-rich varieties in mixed-flower prerolls. That synergy can produce a rounded experience: grounding spice from caryophyllene, wood from humulene, and calming floral notes from linalool. In rosin, pay attention to press temps to retain limonene and ocimene, which volatilize readily. A gentle cure of 2–3 weeks after pressing often clarifies the sandalwood-pepper signature.

Experiential Effects and Use Patterns

Iranian Dove’s onset is typically calm and body-forward, with users reporting a gradual easing of muscular tension and a gentle mental exhale. Inhaled effects start within 2–5 minutes, peak around 30–45 minutes, and taper over 2–3 hours. The headspace tends toward serene and present rather than spacey or chaotic. At moderate doses, it is often described as serene yet functional for low-stimulation activities.

As dosage increases, sedative qualities grow more prominent, consistent with indica-dominant chemotypes rich in myrcene and caryophyllene. Users commonly report enhanced sleepiness later in the session, especially in dim or quiet environments. For some, the line between deeply relaxed and couch-locked arrives quickly, so titration is recommended. Dry mouth and dry eyes are the most frequently reported side effects, occurring in roughly 40–60% and 20–30% of consumers respectively across cannabis broadly.

Anxiety spikes appear less common than with terpinolene-dominant or high-THC sativa-leaning varieties, but high doses can still produce unease in sensitive individuals. Food interest typically increases by 30–60 minutes post-onset, reflecting the usual cannabis appetite effect. Light stretching, guided breathing, or a warm shower pairs well with the body-softening effect profile. The overall experience fits evening wind-down, light media, and sleep preparation.

Edible formulations of Iranian Dove produce a slower onset of 45–120 minutes, with a 4–8 hour duration depending on dose and metabolism. First-time edible users should start at 1–2.5 mg THC and wait at least two hours before redosing. Those experienced with indica edibles often settle in the 2.5–10 mg range for relaxation and sleep support. As always, set and setting shape the experience as much as chemistry.

Potential Medical Uses and Evidence Snapshot

While not a medical product, Iranian Dove’s mostly indica profile and terpene composition align with common patient-reported needs such as sleep support, pain modulation, and anxiety relief. Observational studies and patient regi